Get started
Author

Sam Hillman

ORCID: 0000-0003-0267-4837
Observed ORCID: 0000-0003-0267-4837
OpenAlex ID: A5085486646
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
2022 · Sarah J Stock, Emily Moore, et al. · The Lancet Respiratory Medicine · 73
A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection
2022 · Clara Calvert, Jade Carruthers, et al. · Nature Communications · 42
PDF
Real-World Germline BRCA Testing, Poly(ADP-ribose) Polymerase Inhibitor Utilization, and Survival Outcomes in Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
2025 · Siddhartha Yadav, Fergus J. Couch, et al. · JCO Precision Oncology · 6
PDF
Severity of BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland
2022 · Steven Kerr, Chris Robertson, et al. · The Lancet Regional Health - Europe · 5
PDF
Real-World Treatment Patterns and Outcomes for Patients With Metastatic Triple-Negative Breast Cancer in the United States: An Observational Study
2026 · Simon M. Collin, Sam Hillman, et al. · JCO Oncology Practice · 4
PDF
Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study
2023 · Anna Goulding, Fiona McQuaid, et al. · Archives of Disease in Childhood Fetal & Neonatal · 4
PDF
Real-world tumor BRCA testing patterns and PARP inhibitor use in HER2-negative metastatic breast cancer.
2024 · Siddhartha Yadav, Fergus Couch, et al. · Journal of Clinical Oncology · 3
Real-world treatment patterns and outcomes in hormone receptor–positive, HER2-low metastatic breast cancer, 2018–2023: a retrospective, observational, US cohort study
2026 · Erica L. Mayer, Simon M. Collin, et al. · Breast Cancer Research and Treatment
PDF
Filling the Gaps in Health Data: Using a Machine Learning Approach to Augment Partially Observed Variables Such as Smoking in Claims Data
2026 · Stefan Franzen, Evangelos Chandakas, et al. · Pharmacoepidemiology and Drug Safety
PDF
Abstract P4-10-10: Changing treatment paradigms and unmet needs in patients with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2-) metastatic breast cancer (mBC): Results from health records data
2025 · Alberto Montero, Di He, et al. · Clinical Cancer Research
Abstract P5-07-24: HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study
2025 · Reshma Mahtani, Gregory Vidal, et al. · Clinical Cancer Research
Abstract P3-08-10: Real-world treatment patterns and clinical outcomes for patients with metastatic triple-negative breast cancer (mTNBC) in the United States: an electronic health records observational study
2025 · Tiffany Traina, Sam Hillman, et al. · Clinical Cancer Research
Treatment patterns and clinical outcomes in HER2-low metastatic breast cancer, 2018–2023: A retrospective observational study.
2024 · Erica L. Mayer, Simon M. Collin, et al. · JCO Oncology Practice
Abstract PS04-02: BRCA testing and PARP inhibitor utilization in real-world HER2-negative metastatic breast cancer
2024 · Siddhartha Yadav, Sam Hillman, et al. · Cancer Research
113 Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study
2023 · Fiona McQuaid, Anna Goulding, et al.
Pregnancy Outcomes Following Delta and Omicron SARS-CoV-2 Infection in Scotland: A Population-Based Cohort Study
2022 · Sarah J. Stock, Emily Moore, et al. · SSRN Electronic Journal
Works count: 16
Citation count: 137
H-index: 4
I10-index: 2
Year
Topic
Type